Vertex Pharmaceuticals (VRTX) Earnings Date, Estimates & Call Transcripts $467.74 -2.02 (-0.43%) (As of 10:00 AM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 4EstimatedActual EPS (Aug. 1) -$12.83 Missed By -$0.29 Consensus EPS (Aug. 1) -$12.54 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide Deck Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVRTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VRTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution Vertex Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$3.56$3.73$3.65 Q2 20243($13.85)$3.81($2.16) Q3 20243$3.56$3.68$3.62 Q4 20243$3.60$4.08$3.78 FY 202411($3.13)$15.30$8.90 Q1 20251$3.80$3.80$3.80 Q2 20251$4.04$4.04$4.04 Q3 20251$3.91$3.91$3.91 Q4 20251$3.96$3.96$3.96 FY 20254$15.71$15.71$15.71 Q1 20261$4.10$4.10$4.10 Q2 20261$4.17$4.17$4.17 VRTX Earnings Date and InformationVertex Pharmaceuticals last released its earnings data on August 1st, 2024. The pharmaceutical company reported ($12.83) EPS for the quarter, missing analysts' consensus estimates of ($12.54) by $0.29. The firm had revenue of $2.65 billion for the quarter, compared to the consensus estimate of $2.66 billion. Its revenue for the quarter was up 6.1% on a year-over-year basis. Vertex Pharmaceuticals has generated $15.41 earnings per share over the last year ($15.41 diluted earnings per share) and currently has a price-to-earnings ratio of 30.5. Earnings for Vertex Pharmaceuticals are expected to grow in the coming year, from ($2.14) to $15.93 per share. Vertex Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off prior year's report dates.Read More Vertex Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/4/2024(Estimated)------- 8/1/2024Q2 2024($12.54)($12.83)($0.29)($12.62)$2.66 billion$2.65 billion 5/6/2024Q1 2024$3.66$4.76+$1.10$4.37$2.58 billion$2.69 billion 2/5/2024Q4 2023$3.85$4.20+$0.35$3.43$2.50 billion$2.52 billion 11/6/2023Q3 2023$3.53$4.08+$0.55$3.37$2.50 billion$2.48 billion 8/1/2023Q2 2023$3.47$3.53+$0.06$3.54$2.41 billion$2.49 billion 5/1/2023Q1 2023$2.51$3.05+$0.54$2.65$2.34 billion$2.37 billion The trade we can’t talk about over email (Ad)There is a red-hot sector right now that it seems like Google doesn’t want us to talk about… Because when we talk about it in email, sometimes those messages have trouble making it through to you. And it’s not just email! Videos from Youtube are also being removed. We don’t know exactly why it’s happening… Or if it’s being done manually or by an algorithm…. But we do know that you probably are going to want to see what they’re censoring.Decide for yourself when you get the full details here.2/7/2023Q4 2022$3.11$3.76+$0.65$3.51$2.30 billion$2.30 billion 10/27/2022Q3 2022$3.31$3.62+$0.31$3.65$2.23 billion$2.33 billion 8/4/2022Q2 2022$3.05$3.25+$0.20$3.37$2.13 billion$2.20 billion 5/5/2022Q1 2022$3.17$3.16($0.01)$3.36$2.07 billion$2.10 billion 1/26/2022Q4 2021$2.91$3.18+$0.27$3.36$1.99 billion$2.07 billion 11/2/2021Q3 2021$2.74$3.56+$0.82$3.22$1.85 billion$1.98 billion 7/29/2021Q2 2021$2.25$3.11+$0.86$5.34$1.71 billion$1.79 billion 4/29/2021Q1 2021$2.38$2.98+$0.60$2.59$1.66 billion$1.72 billion 1/31/2021Q4 2020$2.59$2.51($0.08)$2.14$1.58 billion$1.63 billion 10/29/2020Q3 2020$1.96$2.64+$0.68$2.19$1.48 billion$1.54 billion 7/30/2020Q2 2020$1.75$2.61+$0.86$1.34$1.41 billion$1.52 billion 4/29/2020Q1 2020$1.84$2.56+$0.72$2.13$1.28 billion$1.52 billion 1/30/2020Q4 2019$1.21$1.70+$0.49$0.65$1.01 billion$1.41 billion 10/30/2019Q3 2019$0.87$1.23+$0.36$1.72$942.90 million$949.83 million Vertex Pharmaceuticals Earnings - Frequently Asked Questions When is Vertex Pharmaceuticals's earnings date? Vertex Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates. Learn more on VRTX's earnings history. What guidance has Vertex Pharmaceuticals issued on next quarter's earnings? Vertex Pharmaceuticals issued an update on its FY 2024 earnings guidance on Thursday, August, 1st. The company issued revenue guidance of $10.7 billion-$10.9 billion, compared to the consensus revenue estimate of $10.8 billion. Did Vertex Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Vertex Pharmaceuticals (NASDAQ:VRTX) missed the analysts' consensus estimate of ($12.54) by $0.29 with a reported earnings per share (EPS) of ($12.83). Learn more on analysts' earnings estimate vs. VRTX's actual earnings. How can I listen to Vertex Pharmaceuticals's earnings conference call? The conference call for Vertex Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Vertex Pharmaceuticals's conference call transcript? The conference call transcript for Vertex Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Vertex Pharmaceuticals generate each year? Vertex Pharmaceuticals (NASDAQ:VRTX) has a recorded annual revenue of $9.87 billion. How much profit does Vertex Pharmaceuticals generate each year? Vertex Pharmaceuticals (NASDAQ:VRTX) has a recorded net income of $3.62 billion. VRTX has generated $15.41 earnings per share over the last four quarters. What is Vertex Pharmaceuticals's price-to-earnings ratio? Vertex Pharmaceuticals (NASDAQ:VRTX) has a trailing price-to-earnings ratio of 30.48. What is Vertex Pharmaceuticals's EPS forecast for next year? Vertex Pharmaceuticals's earnings are expected to grow from ($2.14) per share to $15.93 per share in the next year. More Earnings Resources from MarketBeat Related Companies: AMGN Earnings Results REGN Earnings Results GILD Earnings Results ALNY Earnings Results BIIB Earnings Results BGNE Earnings Results RPRX Earnings Results UTHR Earnings Results INCY Earnings Results BMRN Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Micron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit Outlook This page (NASDAQ:VRTX) was last updated on 10/2/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Web3 Could Send One Crypto SoaringVenture Capital corporations and blockchain funds are pouring money into Web3 gaming. And there's one littl...Crypto 101 Media | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredKamala’s tax plan is worse than you think—find out whyBuffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredPotential $75B+ Market Opportunity in Aviation…[Investor Alert] Could this Company become The Tesla of Aviation?Market JAR | Sponsored$20 = Ounce of Gold?I've discovered a way to get exposure to MORE than an ounce of gold... for under $20. It's not bullion. It'...Monument Traders Alliance | SponsoredRevolutionary Tech Alert: How Elon Musk is Changing Lives"Elon Musk's Neuralink just received FDA breakthrough status for a revolutionary device designed to restore vi...InvestorPlace | SponsoredThey laughed when he picked Nvidia in 2016…Everyone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
